Agenus | AGEN - Capital Ordinaire





Capital Ordinaire Changement Date
AbbVie USD 1.77B 1.75B 2025-06
Agenus USD 35.32M 2.51M 2025-12
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Celldex Therapeutics USD 66.57M 20K 2026-03
CSL USD 482.13M 93.87M 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Glaxosmithkline GBP 4.05B 20.6M 2026-03
Incyte USD 199.95M 1.49M 2026-03
Intrexon USD 0 0 2024-06
J&J USD 2.41B 1.74M 2025-12
Jiangsu Hengrui CNY 6.64B 0 2026-03
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
MacroGenics USD 63.56M 241K 2026-03
Merck EUR 434.78M 0 2026-03
Merck USD 2.47B 12.72M 2025-12
Northwest Biotherapeutics USD 1.52B 1.52B 2025-09
Novartis USD 1.91B 60K 2026-03
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.7B 13M 2026-03
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Rigel Pharmaceuticals USD 17K 158K 2024-06
Veracyte USD 79.79M 743K 2026-03